This large book contains 26 generally informative and wellwritten chapters addressing various aspects of cell or tumour biology relating to therapeutic responsiveness. The list of contributing authors is distinguished and includes many of the leading experts in their fields.
In her preface, the editor explains her philosophy of regarding therapeutic resistance as a very broad issue involving, amongst other things, cellular biochemistry, tumour physiology and host metabolism. She is clearly correct in doing so, but I still cannot see why the book was given the title which it carries. 'Drug resistance' may be a current 'buzzword(s)', but many of the chapters relate equally to radiation responsiveness as to drug responsiveness, and several have only the most remote connection with either. Something along the lines of 'The Biology of Therapeutic Response in Oncology' would have given a much more accurate idea of the content.
In accord with the philosophy, the book begins with a section entitled 'Physiological Resistance in Solid Tumours'. This consists of seven chapters on topics such as the role of blood flow, pH and oxygenation in tumour metabolism. The second section, 'Biological Resistance', goes on to include topics such as tumour cell heterogeneity, cell population interactions and characterisation of the metastatic phenotype within a total of six chapters. It (submitted) , which is odd to say the least. In late 1993, therefore, the potential reader has, as usual, to ask the question whether, in such rapidly moving fields, the material is sufficiently timely to be regarded as definitive.
The volume contains an enormous amount of valuable material together with some which is less valuable. It is also enormously expensive. I think that it would have been a better book had it attempted to be rather less ambitious and somewhat more focused. It would certainly benefit from a more appropriate title. I believe that it will be bought by some major institutional libraries but I do not think that many individuals will wish to pay the price. The casual reader may well be daunted by the rather austere covers of this weighty tome and by the number of authors-103 in all. However, once Dame Cicely Saunders' foreword has been digested, their appetite will be whetted for the rest of the book. The publication of the Oxford Textbook of Palliative Medicine is both timely and topical; it brings together a wealth of experience from a wide range of disciplines and specialties and provides the most cohesive and comprehensive guide to this evolving field yet available.
In their preface the editors do not address a specific target audience. Cancer nurses, physicians and surgeons, candidates preparing for professional examinations and members of multidisciplinary palliative care teams will all undoubtedly find it a useful resource. In addition, however, this book contains 'something for everyone', including health economists and purchasers of health care. Although the main emphasis, particularly in the chapters on symptom control, is on the palliation of symptoms in patients with malignant disease, wider general principles are expounded which are relevant to patients with symptoms irrespective of their pathology. Specific chapters on paediatric palliative care and palliative aspects of adult acquired immune deficiency syndromes are especially welcome.
Slightly less than half the book is devoted to clear and easily readable reviews of symptom management. These chapters are based on both research and extensive clinical experience, and most authors extend their discussion beyond therapeutic strategies to a consideration of other aspects of their subject, including its pathophysiology. Justifiably long and detailed dissertations on the treatment of major symptoms such as pain and dyspnoea sit well alongside short but pertinent sections on the management of problems as diverse as sweating, lymphoedema and hiccoughs. Unfortunately, areas where the interface between basic science and clinical practice is particularly fruitful and where research is currently active, such as the management of neuropathic pain, are almost by definition already out of date. This is unavoidable, and those chapters which suffer from this drawback are, nonetheless, some of the most interesting.
The reader who still regards palliative care as purely 'terminal care' will be surprised that only 14 of the 817 pages are specifically devoted to the management of the 'terminal phase' of illness. The basic premise that palliative care is active treatment rather than a negative lack of treatment or, as Professor Stjernsward puts it, 'a waste-paper basket alternative' runs throughout the text and unifies the whole. The holistic and interdisciplinary nature of palliative care is emphasised by comprehensive and well-written chapters on ethical, cultural and spiritual issues and bereavement. The section on rehabilitation is noteworthy in that it covers topics as diverse as stoma management and music therapy as well as incontrovertibly demonstrating that rehabilitation is an intrinsic part of palliative medicine.
The importance of research in palliative care is a recurring theme throughout the book, and a specific section is devoted to this topic. Studies in this field are, however, relatively sparse, and the reasons for this are acknowledged and duly addressed. In particular, Calman and Hanks refer to the widespread view that 'scientifically rigorous clinical research is incompatible with the basic tenets of palliative care', and they put forward cogent arguments to refute this. This section of the book is extremely wide-ranging, and discussion is not limited to research into pharmacological and nonpharmacological symptom management as nursing, psychological and social issues are also well covered. The fact that palliative care crosses the traditional barriers of discipline and specialty is highlighted in the section on education and training. The authors stress that all the members of any hospital-based or domiciliary team caring for patients with cancer, be they doctors, nurses, social workers, physiotherapists or clergy, need at least a working knowledge of the philosophy of palliative care and suggest that this subject should become an integral part of the curriculum of all student health care professionals.
Although multiauthorship can bring problems through inevitable variability of both style and approach, these are not very apparent and there is a uniformly high standard of presentation throughout the book. Despite a degree of overlap between chapters there is surprisingly little repetition. The textbook is well indexed and all of the chapters are more than adequately referenced. In parts, the text is rather dry and it is tempting to speculate that it could be lightened by more case histories and illustrations.
The book concludes with a thought-provoking dissertation on the global perpsective of palliative medicine. Each year fifty million people die worldwide. At least 10% die of malignant disease, and it is likely that this proportion, in addition to the numbers dying from AIDS-related diseases, will continue to increase. Given that even in resource-rich, developed nations there is inadequate application of the available knowledge on palliative care, it is perhaps not surprising that globally this field of medicine is badly neglected. To rectify this situation changes are necessary not only in medical practice but also in political, socioeconomic, social and ethical arenas. The World Health Organization has designated palliative care a priority in its Global Cancer Control Programme, and encouraging progress is already being achieved.
The Oxford Textbook of Palliative Medicine is a book both to dip in to, at leisure and when faced with an urgent clinical problem to solve, and to read systematically to gain a full insight into this field. Whilst its publication undoubtedly represents a coming of age of palliative medicine as a specialty in its own right, it is equally obvious that this new specialty must continue to evolve. This book sets out to put forward the rationale for and history to date of integrating chemotherapy and radiation in the management of cancer. The book is divided into five sections, with a brief introduction, the biological principles underlining combined modality therapy, a clinical section covering 17 disease sites, a section on toxicity and an appendix summarising current clinical trials addressing the issue. The second section includes some basic information about the mechanisms and action of both radiation and cytotoxic drugs, but most attention is focused on their use as sole modalities with little information about possible interactions. The clinical chapters are comprehensive and give an excellent overview of combined modality therapy in the individual disease sites. The section on toxicity tends to reproduce some of the information included in the clinical chapters. Overall, this book may be useful as a reference source in a departmental library but it is unlikely to be of everyday relevance to the majority of oncology clinicians. Claude Helene discussed antisense and antigene oligonucleotides and synthetic ribozymes. The major requirements of antisense oligos are emphasised: nuclease stability; preservation of RNAse H activity; good cell penetration. The advantages and shortcomings of the various linker chemistries and the properties of chimaeric molecules comprising conventional phosphodiester linkers in association with methyl phosphonate, phosphorothioate or phosphoramidate units is reviewed. Other chemical manoeuvres, including coupling of oligos to hydrophobic moieties to enhance transport and attachment of alkylating residues, both to achieve nuclease stability and to increase potency, are mentioned also. A consistent theme is the high selectivity that can be achieved with antisense oligonucleotides in their effects, for example on parasitically or virally infected cells, as well as on tumour cells carrying a single point mutation in the Ha-ras oncogene, amplified c-myc or in CML cells, where the bcr-abl translocation can be targeted. Oligonucleotidedirected triple helix formation, where Hoogstein hydrogen bonding permits the association of a third oligo strand with the nuclear DNA, is described as an 'anti-gene' strategy. The triple helix can be effectively stabilised by the attachment of a 'docking' intercalator molecule. It is envisaged that this approach will interfere with the function of transcription factors and restriction enzymes, thus disturbing differentiation and cell division. The author concludes that the
